Carlos Calvo

4.4k total citations
115 papers, 2.8k citations indexed

About

Carlos Calvo is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Carlos Calvo has authored 115 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cardiology and Cardiovascular Medicine, 23 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Nutrition and Dietetics. Recurrent topics in Carlos Calvo's work include Blood Pressure and Hypertension Studies (70 papers), Heart Rate Variability and Autonomic Control (28 papers) and Sodium Intake and Health (16 papers). Carlos Calvo is often cited by papers focused on Blood Pressure and Hypertension Studies (70 papers), Heart Rate Variability and Autonomic Control (28 papers) and Sodium Intake and Health (16 papers). Carlos Calvo collaborates with scholars based in Spain, Chile and United States. Carlos Calvo's co-authors include Diana E. Ayala, Ramón C. Hermida, José R. Fernández, José Enrique López, Artemio Mojón, M. Covelo, M. J. Dominguez, M. J. Fontao, Luís M. Ruilope and Francesco Portaluppi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Advanced Drug Delivery Reviews.

In The Last Decade

Carlos Calvo

112 papers receiving 2.7k citations

Peers

Carlos Calvo
Yasmir Quiroz Venezuela
Felipe Inserra Argentina
R. Davis Manning United States
Camila Manrique United States
Alexandre A. da Silva United States
Naomi D.L. Fisher United States
Yasmir Quiroz Venezuela
Carlos Calvo
Citations per year, relative to Carlos Calvo Carlos Calvo (= 1×) peers Yasmir Quiroz

Countries citing papers authored by Carlos Calvo

Since Specialization
Citations

This map shows the geographic impact of Carlos Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Calvo more than expected).

Fields of papers citing papers by Carlos Calvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Calvo. The network helps show where Carlos Calvo may publish in the future.

Co-authorship network of co-authors of Carlos Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Calvo. A scholar is included among the top collaborators of Carlos Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Calvo. Carlos Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cofán, Montserrat, Marı́a A. Blasco, Nora Soberón, et al.. (2018). The red blood cell proportion of arachidonic acid relates to shorter leukocyte telomeres in Mediterranean elders: A secondary analysis of a randomized controlled trial. Clinical Nutrition. 38(2). 958–961. 17 indexed citations
2.
Ameijeiras, Á. Hermida, et al.. (2017). Arterial stiffness assessment in patients with phenylketonuria. Medicine. 96(51). e9322–e9322. 22 indexed citations
3.
Sala‐Vila, Aleix, Inmaculada Navarro‐Lérida, Miguel Sánchez‐Álvarez, et al.. (2016). Interplay between hepatic mitochondria-associated membranes, lipid metabolism and caveolin-1 in mice. Scientific Reports. 6(1). 27351–27351. 156 indexed citations
4.
Cofán, Montserrat, Carlos Calvo, Antonio J. Amor, et al.. (2016). The proportion of total C18:1 trans -fatty acids in red blood cell membranes relates to carotid plaque prevalence. The Journal of Nutritional Biochemistry. 38. 81–85. 2 indexed citations
5.
Victoria, Berta, José Manuel Cabezas-Agrícola, Giovanna Lattanzi, et al.. (2010). Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy. Diabetic Medicine. 27(10). 1178–1187. 21 indexed citations
6.
Hermida, Ramón C., Diana E. Ayala, Yasser Khder, & Carlos Calvo. (2008). Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: A prospective, randomized, open-label, blinded end-point trial. Clinical Therapeutics. 30(1). 108–120. 17 indexed citations
7.
Araújo‐Vilar, David, Joaquín Lado‐Abeal, Fernando Paz Pellat, et al.. (2008). A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy. Clinical Endocrinology. 69(1). 61–68. 34 indexed citations
8.
Hermida, Ramón C., Carlos Calvo, Diana E. Ayala, et al.. (2007). Dose‐ And Administration Time‐Dependent Effects Of Nifedipine Gits On Ambulatory Blood Pressure In Hypertensive Subjects. Chronobiology International. 24(3). 471–493. 41 indexed citations
9.
Hermida, Ramón C., Carlos Calvo, Diana E. Ayala, et al.. (2005). Administration Time‐Dependent Effects of Valsartan on Ambulatory Blood Pressure in Elderly Hypertensive Subjects. Chronobiology International. 22(4). 755–776. 51 indexed citations
10.
Hermida, Ramón C., Diana E. Ayala, Carlos Calvo, & José Enrique López. (2005). Aspirin Administered at Bedtime, But Not on Awakening, Has an Effect on Ambulatory Blood Pressure in Hypertensive Patients. Journal of the American College of Cardiology. 46(6). 975–983. 86 indexed citations
11.
Bernat, Amparo, et al.. (2004). Seguimiento a largo plazo de catéteres permanentes en pacientes con dificultad en la obtención de un acceso vascular definitivo. Nefrología. 24(5). 446–452. 2 indexed citations
12.
Núñez, Juan F. Macías, et al.. (2003). Verapamil Reverts Acute Renal Functional Impairment Induced by Angiotensin II Converting Enzyme Inhibitors. Renal Failure. 25(5). 727–737. 3 indexed citations
13.
Ruilope, Luís M., et al.. (2003). Efecto del tratamiento antihipertensivo con irbesartán sobre el riesgo cardiovascular absoluto. Revista Clínica Española. 203(4). 183–188. 2 indexed citations
14.
Hermida, Ramón C., Carlos Calvo, Diana E. Ayala, et al.. (2002). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. Journal of the American College of Cardiology. 40(4). 710–717. 83 indexed citations
16.
Hermida, Ramón C., Carlos Calvo, Diana E. Ayala, Artemio Mojón, & José Enrique López. (2002). Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients. Journal of Hypertension. 20(6). 1097–1104. 112 indexed citations
17.
Mosquera, Alejandro, et al.. (2002). Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen status. Journal of Hypertension. 20(7). 1365–1372. 15 indexed citations
18.
Bustos, Paulina, Natalia Ulloa, Carlos Calvo, et al.. (2000). Monoclonal antibodies to human apolipoproteins: application to the study of high density lipoprotein subpopulations. Clinica Chimica Acta. 299(1-2). 151–167. 2 indexed citations
19.
Calvo, Carlos, Gabriel Ponsin, & F Berthezène. (1988). Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.. PubMed. 14(3). 264–9. 28 indexed citations
20.
Calvo, Carlos, et al.. (1988). Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties. Biochemical and Biophysical Research Communications. 153(3). 1060–1067. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026